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Mammalian lipoxygenases oxygenate free arachidonic acid to a variety ofbiologi-
cally active metabolites. Products oftheselipoxygenase pathways includemono- and
dihydroxyeicosanoids, leukotrienes, and lipoxins (1-3). Monohydroxyeicosatetraenoic
acids (HETEs)t have been shown to influence cellular migration, phospholipases,
fatty acid oxygenases, and secretionofcellular constituents, and tomodulate several
immune responses (4). 5,15-DiHETE and 8,15-diHETE have been reported to en-
hance FMLP-induced superoxide generation in neutrophils and to stimulate pro-
tein kinase C activity (5, 6). Leukotriene B4 is avery potent chemotactic agent, leu-
kotrienes C4, D4, and E4 induce airway constriction, hypotension, and plasma
extravasation, andthe lipoxinshave been shown tostimulate superoxide generation,
inhibit the cytotoxicactivity ofhuman NK cells, andactivate protein kinase C (2, 3, 6).
Anumberofinvestigators havepresentedevidence that certain cellularlipoxygenases
exist in an inactive or cryptic state until properly stimulated. Thus, Ca2+ and ATP
were shown to activate the 5-lipoxygenase in leukocytes and rat basophilic leukemia
cells (7, 8). We have previously demonstrated that the 5-lipoxygenase in themurine
PT18 mast/basophil cell line was stimulated by 15-HETE, a product of the 15-
lipoxygenase (9). In addition, we recently reported that several HETEs were able
to activate the 15-lipoxygenase in human neutrophils (10). The common feature of
all these studies was that the arachidonic acid substrate was added exogenously to
either cells or lipoxygenase preparations. In this report, we describe experiments
designed to examine whether the human neutrophil 15-lipoxygenase can be selec-
tively stimulated to oxygenate endogenous arachidonic acid.
Materials and Methods
5(S)-HETE and 5(S),15(S)-diHETE were purchased from BioMol Research Labs., Inc.
(Plymouth Meeting, PA). Leukotriene 134 (LTB4), lipoxin A4 (LXA4), and LXB4 were gener-
ously provided by Dr. J. Rokach, Merck-Frosst, Quebec, Canada. 12-HETE was prepared
from human platelets (AmericanRed Cross, Washington DC), and 15-HETE was prepared
using soybean lipoxygenase as previously described (11). The methyl ester of 5-HETE was
prepared by treating 5-HETE with ethereal diazomethane at room temperature for 15 min.
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The ester was purified by straight-phase HPLC (SP-HPLC). To verify retention times on
reverse-phase (RP)- and SP-HPLC, racemic monoHETEs were prepared by singlet oxygen
oxidation ofarachidonic acid as previously described (12). All hydroxyeicosanoids were evalu-
ated for purity by RP-HPLC before use.
Blood was obtained by venipuncture from human donors who had not taken aspirin or
aspirin-like drugs for the previous 2 wk. Neutrophils were isolated from heparinized blood
by a modified Ficoll-Hypaque technique according to the procedure of Ferrante and Thong
(13). The neutrophil layer was collected and washed in assay buffer (Dulbeccds PBS, 10 mM
dextrose, pH 7 .4). Red cells were removed by hypotonic lysis. Cell viability was evaluated
by trypan blue exclusion and was consistently >99%. Red cell contamination was <1%, and
the platelet concentration was never >1:1, with respect to neutrophils, and in most cases was
much less. Cells were diluted to 2 x 107/ml.
Neutrophils were prelabeled as follows. First, [3H]arachidonic acid (100 Ci/mmol, DuPont
Co., Wilmington, DE) was dried under nitrogen and dissolved in ethanol before use. Ethanol
concentration in the prelabeling buffer was never >0.05%. After addition of arachidonic acid
(8 gCi/ml of cells), cell suspensions were incubated in a 37°C shaking waterbath for 90 min
with intermittent mixing. Cells were washed three times with equal volumes of assay buffer
containing 0.1% BSA (Sigma Chemical Co., St. Louis, MC). After two washes, the amount
ofradiolabeled free arachidonate released into the washingbuffer did not significantly change.
Prelabeled neutrophils were diluted to 2 x 107 cells per ml of assay buffer and stored at room
temperature before the assay.
To test the effects of hydroxyeicosanoids on [3H]arachidonate-prelabeled neutrophils, these
compounds were first dried under nitrogen, dissolved in buffer, and kept on ice. At time zero,
hydroxyeicosanoids were added to the prelabeled neutrophils, which were placed in a 37°C
shaking waterbath. No additions were made to control tubes. The incubations were stopped
by adding the reaction mixture to a tube containing 3 vol of methanol.
To evaluate the viability of cells after treatment with hydroxyeicosanoids, the activity of
the cytosolic enzyme lactate dehydrogenase was measured in supernatants (14). Lactate de-
hydrogenase release of hydroxyeicosanoid-treated samples did not differ significantly (mean
f SEM = 101 t 5%, n = 16) from control samples.
After addition of an internal standard (1 jig prostaglandin B2 [PGB2]) to the methanolic
cell suspension (sample recovery typically ranged from 70 to 90%), lipids were extracted by
a modified Folch procedure (10). The chloroform layer was removed and stored at -20°C
until analysis. A mixture of monoHETEs was added to correlate the retention time of the
neutrophil lipoxygenase products. All solvents were HPLC grade (Fisher Scientific Co.,
Fairlawn, NJ). After removal of chloroformfrom the samples by evaporation under nitrogen,
the samples were dissolved in 50 Al acetonitrile/water (65:35) immediately before injection
on RP-HPLC. Separation was performed on a Zorbax (DuPont Co.) octadecasilane 0.46 x
25-cm column attached to a solvent programmer, LC 85B variable wavelengthUV detector,
and Series 4 liquid chromatograph (Perkin Elmer Corp., Norwalk, CT). Eluate fractions were
collected with a fraction collector (2211; LKB Produkter, Bromma, Sweden). Retention times
were monitored with a plotter/integrator (3369A; Hewlett-Packard Co., Palo Alto, CA). For
separation of radiolabeled monoHETEs, a solvent mixture consisting of 57% acetonitrile,
33% water (pH 3 .7), and 10% methanol was run isocratically for 33 min. Retention times
for the major lipoxygenase products were: 15-HETE, 19.2 min; 12-HETE, 22.4 min; and
5-HETE, 25.3 min. The PGB standard eluted at 7.1 min. It should be notedthat the varia-
tion in retention times in both SP- and RP-HPLC was >5%, and was proportional for each
component. To quantify free [3H]arachidonate, the eluting solvent composition was changed
to 100% methanol during a 5-min gradient and then run isocratically for 30 min. Arachidonate
eluted at 47 min (the retention time of arachidonic acid was 75 min in the HPLC analyses
used to separate the HETE methyl esters). To verify the arachidonic acid retention times,
separate analyses were performed with authentic [3H]arachidonate. Lipoxygenase product
formation and arachidonate levels were determined by liquid scintillation counting of 1-min
fractions (0.3-min fractions in the monoHETE region) in 3a70B scintillant (Research Prod-
ucts International Corp., Mt. Prospect, IL) on a liquid scintillation counter(LS-3801; Beckman
Instruments, Inc., Fullerton, CA). Results were corrected for recovery ofthe internal standard.NICHOLS AND VANDERHOEK
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To further confirm the identities of the radioactive products, HETE analyses were also
performed by SP-HPLC using a silicic acid column (0.46 x 25 cm) (Alltech Associates, Inc.,
Deerfield, IL) and a combination of solvent A (99% hexane, 0.1 17o acetic acid) and solvent
B (89.9% hexane, 10.0% isopropanol, 0.1% acetic acid). 10% solvent B was run isocratically
for 10 min, followed by a 15-min gradient to 90% B, and run isocratically at 90% B for 30
min. The major monoHETEs eluted at the following times: 12-HETE, 12.9 min; 15-HETE,
14.6 min; 5-HETE, 25.6 min.
In some experiments, cellular lipid classes were separated by silicic acid chromatography.
Samples were dried, dissolved in ethyl acetate/hexane (5:95), and added to a Sep-Pak car-
tridge (C18; Millipore Continental Water Systems, Bedford, MA). Eluates were character-
ized by thin-layer chromatography. The cartridge was first eluted with 5% ethyl acetate, which
removed neutral lipids, including triglycerides. Next, the eluting solvent was changed to 20°Io
ethyl acetate in hexane, which eluted arachidonic acid and HETEs. Finally, phospholipids
were eluted with methanol.
To assess the esterified monoHETE content ofcellular lipids, the phospholipid sample was
dried under nitrogen and treated with methanolic NaOH (0.2 M) in chloroform at room
temperature for 15 min (15). The mixture was acidified, and the fatty acid methyl esters were
extracted into chloroform. The samples were stored at -20°C until analysis. To separate
monoHETE methyl-esters by RP-HPLC, the isocratic mode described above was extended
to 60 min. The retention times of 5-, 12-, and 15-HETE remained the same (see above),
and the retention times of the methyl esters were: 15-HETE-ME, 41 min; 12-HETE-ME,
46 min; and 5-HETE-ME, 54 min.
In experiments designed to quantify the mass ofnonesterified arachidonic acid in unlabeled
neutrophils (40-6.5 x 107 cells), chloroform-extracted lipids were analyzed by SP-HPLC
using the silicic acid column (Alltech Associates, Inc.) and a modification of a recently de-
scribed method (16). In this system, the composition of solvent C was 95.2% hexane, 4.8%
methyl tert-butyl ether, 0.02% acetic acid; and solvent D was 70% hexane, 30% methyl tert-
butyl ether, 0.02% acetic acid. 100% solvent C was run isocratically for 20 min at 1 ml/min fol-
lowed by a 2-min gradient to 100% solvent D. A 30-min isocratic phase completed the solvent
program. In addition, 0.1 uCi [3H]arachidonate (1 pmol) was added as an internal standard
to all samples. Authentic arachidonate and [3H]arachidonate coeluted at 13.5 min. Free ar-
achidonic acid in experimental samples was determined from the absorbance at 210-213 nm
using a standard curve generated on the same day. [3H]Arachidonic acid always coeluted
with unlabeled arachidonate and was used to determine recovery. The arachidonic acid peak
was isolated and analyzed by capillary gas chromatography in order to confirm its identity.
In experiments designed to determine whether treatment of unlabeled neutrophils with
12-HETE could produce 15-HETE, the cells (10') were incubated with 43-AM 12-HETE
for 8 min at 37 °C. Products were extracted into chloroform and analyzed by RP-HPLC.
The material eluting with a retention time identical to that of authentic 15-HETE was col-
lected and assayed by RIA as previously described (17). The crossreactivity of the antiserum
to 12-HETE was 0.1%.
Results
Human neutrophils were prelabeled by incubating cells with [3H]arachidonic acid
(4 p,Ci/107 cells) for 90 min at 37°C. Analysis of the cells indicated that 65 t 3%
of the label was incorporated into the phospholipid fraction and 33 t 3 % into the
neutral lipid fraction, and that 0.5-2% was free [ 3H]arachidonic acid (four sepa-
rate experiments). Treatment of prelabeled neutrophils with exogenously supplied
5-HETE for 30 min at 37°C stimulated the 15-lipoxygenase, as shown by the forma-
tion of [3H]-15-HETE (Fig. 1). At concentrations of 8 or 25 ,UM, exogenously added
5-HETE also stimulated the neutrophil 5-lipoxygenase activity, as indicated by the
formation of [3H]-5-HETE. The metabolites were identified on the basis of their
retention times on RP- and SP-HPLC in comparison with authentic standards. Under370
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these conditions, <0.1% conversion of 5-HETE to 5,15-diHETE was observed (in
three experiments, an average of <1 ng of 5,15-diHETE was formed from 4 Ag of
5-HETE).
To determine which structural features in the 5-HETE molecule are important
to specifically stimulate the neutrophil lipoxygenases, the effects ofseveral analogs
and derivatives of 5-HETE were examined. The results in Fig. 2 show that 5,15-
diHETE was the most selective stimulator of the 15-lipoxygenase tested, whereas
LTB4, the other dihydroxyeicosanoid, and 5-HETE methyl ester were equipotent
but somewhat less selective. Exogenously added 15-HETE and 12-HETE were the
least potent activators. Several experiments were carried out comparing the stimula-
tory activities of5-HETE, LXA4, and LXB4. At 25 j.M, 5-HETE was about twice
as effective as LXB4 (8 IAM) in stimulating the neutrophil 15-lipoxygenase, and was
four times more potent than LXA4 (8 ttM) (results not shown). A dose-response
relationship of5,15-diHETEonthe neutrophil lipoxygenases indicated that concen-
trations as low as 1 gM exhibit a selective stimulation of the 15-lipoxygenase (Fig.
3). In addition, the time course showed that maximal stimulation occurred after
30 min, which did not change after 1 h (Fig. 4). Time course studies with 5-HETE
yielded similar results (data not shown).
During the HPLC analyses of the reaction mixtures, it was observed that free
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FIGURE 1.
￿
Effect of 5-HETE on the 5- and 15-
lipoxygenase activities in human neutrophils.
Human neutrophils (107), prelabeled with [3H]ar-
achidonic acid, as described in Materials and
Methods, were incubated in the presence or ab-
senceof 5-HETE for30 min at 37°C. Products
were extracted and analyzed by RP-HPLC.
Production of [3H]5-HETE and [3H]15-HETE
wasused to indicate the 5- and 15-lipoxygenase
activities, respectively. Themean value t SEM
from three to five experiments are presented.
FIGURE 2.
￿
Effect of different
hydroxyeicosanoids andstearic
acid on the human neutrophil
lipoxygenase activities. [3H]Ar-
achidonic acid-prelabeled hu-
man neutrophils (107) were
treated in the absence or pres-
ence ofdifferent hydroxyeicosa-
noidsor stearic acid for30 min
at 37°C. Thefattyacid concen-
trationused was25 pM, except
for leukotriene B4, which was
tested at 8kM. The formation
of [3H]5-HETE and [3H]15-
HETE wasquantitated by RP-
HPLC and liquid scintillation
counting. The results are ex-
pressed as the mean t SEMof
three to five experiments.0 E
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FIGURE 3.
￿
Concentration dependence of the
stimulatory effect of 5,15-diHETE on the 15-
lipoxygenase in human neutrophils. Human neu-
trophils (107), prelabeled with [3H]arachidonic
acid, were incubated with the indicated concen-
trations of 5,15-diHETE. [3H]HETE formation
was measured as described in Materials and
Methods. Data representthe mean t SEM from
0
￿
1
￿
3
￿
8
￿
25
￿
three to six separate experiments.
EXOGENOUSLY ADDED 5,15-diHETE ("M)
O-O CONTROL
0- 0
￿
5,15-d[HEM
￿
FIGURE 4.
￿
Time course of the stimulation
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prelabeled with [3H]arachidonic acid, were
incubated at 37°C for various periods of time
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in the absence (control) or presence of 8 pM
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5,15-diHETE. [3H]15-HETE formation, a
measure of 15-lipoxygenase activity, was de-
terminedby RP-HPLC. Values are the mean
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t SEM from three different experiments.
INCUBATION TIME (min)
[3H]arachidonic acid was the largest fatty acid component in both control samples
and hydroxyeicosanoid-treated cells, averaging 43,000 t 15,000 dpm/107 cells (n =
9; range of values, 10,000-156,000 dpm). Although almost all of the [3H]arachidonic
acid is incorporated into cellular lipids, N0.5-2% of the [3H]arachidonic acid re-
mains nonesterified. It was not possible to remove this cell-associated but free fatty
acid pool ofarachidonicacid even afterrepeated washings. The data in TableI show
TABLE I
Release of (3HJArachidonic Acid from Prelabeled
Human Neutrophils into Buffer
Treatment
￿
[3H]Arachidonic acid released into buffer
dpm x 10-31107 cells
Prelabeling protocol
￿
403 t 54
First wash
￿
37 t 5 .4
Second wash
￿
24 t 3 .2
Third wash
￿
20 t 2 .7
Neutrophils (2 x 107/ml Dulbecco's PBS, pH 7.4, containing 10 mM dextrose)
were incubated with [3H]arachidonic acid (8 juCi/2 x 107 cells) for 90 min at
37°C. The medium was removed by centrifugation and its radioactivity content
measured. The cells were resuspended in buffer (containing 0.1 % BSA) at the
same concentration. After 5 min, the supernatant (first wash) was removed by
centrifugation and its radioactivity content was measured. The radioactivity was
identified as [3H]arachidonic acid by thin layer chromatography. The washing
procedure was repeated twice more. Values are the mean t SEM for five different
experiments.37 2
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that after the second wash, the same amount of [3H]arachidonic acid was released
into the washing buffer as was released after the third wash. Similar results were
observed after a fourth wash (results not shown). Moreover, free [3H]arachidonic
acid levels did not appreciably change when [3H]arachidonic acid-prelabeled cells
were incubated at 37°C over a 60-min period (10-min incubation, 39,000 t 6,000
dpm/107 cells [n = 3]; 30-min incubation, 43,000 t 12,000 dpm/107 cells; 60-min
incubation, 47,000 t 6,200 dpm/107 cells).
These results prompted us to perform several experiments using unlabeled neu-
trophils. The amount of nonesterified, but cell-associated, arachidonic acid in these
cells wasdetermined by Folch'sextraction and SP-HPLC. The results shown in Table
II indicated that the endogenous pool of free arachidonic acid in cells from four
different donors ranged from 30 to 670 ng/107 cells. No significant differences in
free arachidonate were evident betweencontrol and stimulated (8 AM 5,15-diHETE)
samples. In two of the donors, little increase in free arachidonate was observed be-
tween nonincubated cellsand cellsincubated at 37°C for30 min. In separate experi-
ments, unlabeled neutrophils were treated with 12-HETE (43 LM), followed by ex-
traction of products andanalysis by RP-HPLC. Thematerial elutingwith aretention
time identical to that of authentic 15-HETE was collected andquantitated by RIA.
12-HETE-treated neutrophils produced 4.0 f 1.0 ng 15-HETE/107 cells (three sep-
arate experiments), whereas no 15-HETE (<0.1 ng/107 cells) could be detected in
untreated cells.
Discussion
Human neutrophils have been reported to contain the 5- and 15-lipoxygenases,
and various studies have demonstrated that these cellular lipoxygenases need to be
stimulated in order to metabolize exogenously supplied substrate (2, 7, 8, 10). The
present studies show that endogenous free arachonidonic acid can be used when
the inactive 15-lipoxygenase is stimulated in both unlabeled and in [3H]arachidonic
acid-prelabeled neutrophils, as evidencedby formationofimmunoreactive 15-HETE
or [3H]-15-HETE, respectively.
The structure-function studies indicate that stimulation of the 15-lipoxygenase
TABLE II
Free Arachidonic Acid Levels in Human Neutrophils
Human peripheral blood neutrophils (unlabeled, 4.0-6.5 x 107) were isolated
and incubated at 37°C for 30 min in the absence (control, 30 min) or presence
of8 uM 5,15-diHETE. Other control samples were not incubated at 37°C, but
were immediately extracted into chloroform (0-min control). After the incuba-
tion was terminated, the lipids were extracted and free arachidonic acid was quan-
titated by SP-HPLC as described in Materials and Methods.
Donor
Control
0 min
cells
30 min
5,15 diHETE-treated cells
30 min
ng/10' cells
BD 30 36 27
ME 63 77 95
RN 47 82 90
TS 670 - 470NICHOLS AND VANDERHOEK
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is not ageneral property offattyacidssince stearicacid was ineffective. The position
of the hydroxyl group seems to be important since 5-hydroxyeicosanoids were ap-
preciably more potent stimulators than either 12- or 15-HETE. The low amount
of [3H]-5-HETE formation in the presence of exogenous 15-HETE may be due to
the previously reported inhibitory activity of 15-HETE on the neutrophil 5-lipoxy-
genase (18). The effectivenessof5-HETE methyl ester indicatesthat afree carboxyl
functionality is not essential. The presence of a second hydroxyl group appears to
increase the selectivity of stimulating the 15-lipoxygenase relative to the 5-lipoxygenase.
Since LXA4 and LXB4 were less potent than either 5-HETE or 5,15-diHETE, this
suggests that the presence of three hydroxyl groups and/or different positions and
stereochemistries of the double bonds may adversely affect the stimulatory poten-
cies of hydroxyeicosanoids on the 15-lipoxygenase. The relative inability of most of
these hydroxyeicosanoids to stimulate the 5-lipoxygenase and the observation that
FMLP wasineffective in stimulatingthe 15-lipoxygenase (results not shown) suggest
that the mechanisms of stimulation of the 5- and 15-lipoxygenase are different.
Transesterification data indicate that 98-99% of the [3H]arachidonic acid was es-
terified into cellular lipids (results not shown), and about two-thirds of this [3H]ar-
achidonic acid was found in the phospholipid fraction. No significant increase in
[3H]arachidonic acid release was observed when prelabeled cells were treated with
5,15-diHETE relative to controlcells. This suggests that 5,15-diHETEdidnotstimulate
the neutrophil phospholipase, which makes it unlikely that any HETEs esterified
into cellular lipids would be liberated. Although it is possible that other hydroxy-
eicosanoids could stimulate cellular phospholipases to release free [3H]arachidonic
acid, this is considered unlikely in view ofthe report by Chang et al. (19), whofound
that 5-, 12-, and 15-HETE inhibited the rat neutrophil phospholipase A2. A more
probable source of substrate is a pool ofcell-associated but nonesterified arachidonic
acid. Washing the cells did not remove this pool, since the amount of [3H]arachi-
donic acid released after several washes reached aplateau level. The size of this pool
was -40,000 dpm (or -180 fmol/10' cells), which suggests that the hydroxyeicosa-
noids shown in Fig. 2 metabolized -0.5-3% of substrate. It should be noted that
a similar pool of free arachidonic acid associated with the cell pellet of prelabeled
neutrophils has recently been described (20). Analyses of unlabeled neutrophils
confirmed the presence of an endogenous pool of free arachidonic acid. This pool
size in four donors ranged from 30 to 670 ng/107 cells, with a mean of 200 ng. This
value suggests that treatment of unlabeled neutrophils with exogenous 12-HETE
resulted in a 2% conversion to 15-HETE, well within the range found with prela-
beledneutrophils. Whetherthis pool ofcell-associatedbut nonesterified arachidonic
acid is normally presentin vivo or is released during thecell isolation and/or washing
procedures cannot be ascertained.
Various studies have demonstrated that HETEs are incorporated into membra-
nous lipids (21, 22). To determinewhetherexogenouslyadded 5,15-diHETEinfluenced
the incorporation of [3H]arachidonic acid metabolites into neutrophilic phospho-
lipids, cellular phospholipids were isolated and separated from other lipid classes.
The phospholipidswere then transesterified by treatment with methanolic sodium hy-
droxide and thefatty acid methyl esters analyzed by RP-HPLC. The analyses showed
that >99% of the tritium-labeled methyl esters were methyl [3H]arachidonate, with
the remainder consisting primarily of [3H]-HETE methyl esters. In 5,15-diHETE374
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(8 IAM)-treated neutrophils, no significant change (relativeto controls)in theamount
of either [3H]-5-HETE or [3H]-15-HETE incorporated into phospholipids was ob-
served (results not shown).
In conclusion, the results of the present study provide additional support for the
hypothesis that certain cellular lipoxygenases, such as theneutrophil 15-lipoxygenase,
exist in cryptic states. Furthermore, 5-hydroxyeicosanoids, the metabolites that are
produced by the other neutrophil lipoxygenase, are capable of stimulating the 15-
lipoxygenase. This further confirms previous observations that complex interrela-
tionships exist between cellular lipoxygenases and lipoxygenase metabolites (18). It
is possible that 5-hydroxeicosanoids may mimic an unidentified physiological acti-
vator of the cryptic 15-lipoxygenase.
Summary
When human neutrophils, prelabeled with [3H]arachidonic acid, were incubated
with 5S,15S-dihydroxyeicosatetraenoic acid (5,15-diHETE), adose-dependent increase
in the 15-lipoxygenase product [3H]-15-HETE was observed relative to untreated
cells. Typically, a fivefold increase in [3H]-15-HETE formation was obtained upon
exposure of these cells to 3 j.M 5,15-diHETE. There was no appreciable enhance-
ment of the 5-lipoxygenase metabolite [3H]-5-HETE. Product identities were
confirmedby comparing retention times on straight- and reversed-phase HPLC with
authentic standards, and RIA. Other 5-hydroxyeicosanoids, such as 5-HETE, 5-
HETE methyl ester, and leukotriene B4(5S,12RdiHETE), were equally effective in
stimulating the formation of [3H]-15-HETE, but exogenously added lipoxin A4,
lipoxin B4, 15-HETE, and 12-HETE were much less potent, whereas stearic acid
was ineffective. The diHETEs also showed agreater selectivity in activating the 15-
lipoxygenase relative to the 5-lipoxygenase.
Alikely source ofsubstrate for the 15- and 5-lipoxygenases is apool of cell-associated
but noncovalently bound arachidonic acid. In [3H]arachidonic acid-prelabeled neu-
trophils, the amount of free [3H]arachidonic acid ranged between 50 and 700
fmol/107 cells, whereas unlabeled neutrophils contained 100-2,200 pmol/107 cells of
nonesterified arachidonic acid. The exogenously added hydroxyeicosanoids induce
a 0.5-3% conversion of this substrate pool to product.
These findings indicate that the 15-lipoxygenase in humanneutrophils is acryptic
enzyme that needs to be stimulated in order to metabolize endogenous substrate.
It is possible that 5-hydroxyeicosanoids may mimic an as yet unidentified physiolog-
ical activator of the 15-lipoxygenase.
We thank Dr. Norberta Schoene of the Lipid Nutrition Laboratory, Agricultural Research
Service, USDA, for kindly performing the gas chromatography analyses.
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